WHODrug portfolio

One complete reference guide for precise drug coding, better patient safety and safer medicines

How to subscribe

A safer medicine life cycle

With its standardised data, WHODrug Global is the first point of reference in clinical trials and post-marketing surveillance.

The WHODrug portfolio of trusted and unique products and services increases patient safety by guaranteeing the effective and efficient identification of medicines. By using WHODrug Global, you will get a better understanding of patient profiles and improve your analysis of underlying treatments and safety concerns.

As a non-profit foundation, UMC uses the income generated by sales of the WHODrug portfolio of products and services to support and develop pharmacovigilance around the world.

Service interruption

Due to a problem with our IT provider, several of UMC’s online services are currently unavailable. We apologise for the disruption and we are working with our provider to restore normal service as soon as possible. Check our status page for more details...

WHODrug Global

Combining comprehensive drug information and powerful analytical tools, WHODrug Global is the most widely used drug dictionary internationally. One subscription meets all your needs in assessing drug safety.

WHODrug Koda

WHODrug Koda is a powerful and fully automated drug coding assistant that uses AI and advanced algorithms for more efficient and consistent drug coding. It is available now as an add-on to your existing WHODrug Global subscription.

Read more

WHODrug Koda

WHODrug Global Chinese

WHODrug Global Chinese provides quality assured information for coding directly in Chinese. It also simplifies the regulatory approval process both inside and outside China with instant translations of English and Chinese drug information.

Read more 了解更多

WHODrug Global Chinese

How to subscribe

Everything you need to know about signing up and becoming a member of the WHODrug community.

Read more

How to subscribe